Dr Cristina Vilaplana is a medical doctor passionate about helping patients with tuberculosis (TB). Her research could make a difference to a lot of people.

RESIST-TB released its June 2023 newsletter with the latest updates and research publications on drug-resistant TB.

Ready Next Time is a report by Campaigns in Global Health that maps the intersection between efforts to strengthen pandemic prevention, preparedness and response systems and efforts to end TB. It sets out how policymakers and funders can deliver impact across both agendas, saving lives today and tomorrow and helping to make the case for sustained investment in public health.

The University of California at San Francisco and Berkeley Tuberculosis Research Advancement Center (UC TRAC) is launching a Tuberculosis Community Advisory Board (UC TB-CAB) in August 2023.

Researchers will conduct clinical trials in the United Arab Emirates (UAE) on a breath analyser that is said to be able to detect tuberculosis (TB) in minutes.

8 June 2023 | Geneva -- Today the World Health Organization (WHO) and the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) signed a new and revised Strategic Framework for Collaboration, designed to build stronger and more resilient health systems and maximize collaboration and impact in support of country, regional and global responses to major communicable diseases. 

Tuberculosis is set to overtake Covid-19 as the world’s most deadly infectious disease, with medical experts warning its resurgence represents a “ticking timebomb” healthcare emergency.

The study, recently published in the journal Cureus, also found that a severe form of vitamin D deficiency -- less than 10 nanogrammes per millilitre (ng/mL) -- was higher among children with TB.

22 May 2023 -- Quratis said on Monday that the phase 2a clinical trial results of its novel tuberculosis (TB) vaccine for adults and adolescents, QTP101, showed excellent safety and immunogenicity.

5 June 2023 | Geneva-- The World Health Organization (WHO) Global Tuberculosis Programme is launching a new online platform to track progress in the development of new treatment regimens, vaccines as well as operational research projects designed to improve TB prevention, treatment, and care.